Epilepsy Drug Market Outlook Brightens as Clinical Trial Pipelines Show Promising Results
The global epilepsy drug market is projected to reach US$ 27.6 billion by 2033, up from US$ 17.8 billion in 2023. This reflects a steady CAGR of 4.3% from 2024 to 2033. One of the main drivers behind this growth is the increasing number of people being diagnosed with epilepsy.